Autoimmune Disease Therapeutics Market projected for significant growth from 2025 to 2035, driven by biologics, innovation, and rising prevalence Global demand for autoimmune disease therapeutics is ...

Feds file smuggling charge against Petrova after Judge Christina Reiss questioned a CBP officer's authority to strip her of ...

Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received seven years of orphan-drug exclusive approval from U.S.

She received a state-of-the-art bio-implant that has miraculously regulated the condition with minimal invasiveness — and ...

Future research into non-Hodgkin lymphoma treatments needs to explore long-term outcomes and a better understanding biologic ...

SEOUL, May 15 (Yonhap) -- Celltrion Inc., a leading South Korean biopharmaceutical company, said Thursday its business will ...

Risk for the autoimmune hair disorder was reduced by nearly 75% in patients on these treatments for psoriasis, finds a ...

The winner of this year's MIT $100K Entrepreneurship Competition is helping advanced therapies reach more patients faster with a new kind of ...

Treatment with JAK inhibitors was associated with a greater risk of infections compared with biologic therapies in patients with atopic dermatitis.

Slow progress, pipeline uncertainty & lack of catalysts weigh despite strong cash. Click to read why KYMR stock is a Hold.

In April, the Company confirmed that it currently faces no material exposure to newly imposed U.S. tariffs. BioRestorative ...

Following completion of the dose escalation phase in relapsed/refractory acute leukemia patients with FLT3 mutations, Biomea ...